A concise review of angiofibroma of soft tissue: A rare newly described entity that can be encountered by dermatopathologists

J Cutan Pathol. 2020 Feb;47(2):179-185. doi: 10.1111/cup.13580. Epub 2019 Oct 13.

Abstract

Angiofibroma of soft tissue (AFST) is a newly described, rare mesenchymal neoplasm with fibroblastic and vascular components; it can be seen in both sexes and in a broad age range. It presents as a slowly enlarging mass, most often in the deep tissues of the upper and lower extremities, but occasionally in a superficial location where it may be encountered by dermatopathologists. It has a benign clinical course with a very low probability of recurrence after complete excision. This lesion has a prominent vasculature and may have an infiltrative growth pattern. These features could lead to a misdiagnosis, such as malignant vascular tumor, by an unwary dermatopathologist. The diagnosis of AFST initially relied solely on morphology and immunohistochemistry but, more recently, molecular studies have begun to play a role. Because of the potential for misdiagnosis, we present this review to raise awareness.

Keywords: FISH; NCOA2; angiofibroma; soft tissue.

Publication types

  • Review

MeSH terms

  • Angiofibroma* / diagnosis
  • Angiofibroma* / metabolism
  • Angiofibroma* / pathology
  • Diagnostic Errors
  • Humans
  • Soft Tissue Neoplasms* / diagnosis
  • Soft Tissue Neoplasms* / metabolism
  • Soft Tissue Neoplasms* / pathology
  • Vascular Neoplasms* / diagnosis
  • Vascular Neoplasms* / metabolism
  • Vascular Neoplasms* / pathology